论文部分内容阅读
比较血管紧张素转换酶抑制剂（ ACEI）与血管紧张素Ⅱ受体拮抗剂（ ARB）治疗冠心病的疗效：在全因死亡、心血管死亡、心肌梗死及心力衰竭治疗方面，ARB与ACEI无明显差异，但ARB因不良反应而停药方面优于ACEI。结论：ARB治疗冠心病在全因死亡、心血管死亡、心肌梗死及心力衰竭治疗方面，疗效与ACEI相似而耐受性更好。“,”In comparison to the effect of angiotensin converting enzyme inhibitors( ACEI) and angiotensinⅡreceptor blockers( ARB) in treating coronary heart disease:in all-cause mortality and cardiovascular mortality、myocardial infarction and heart failure,there was no sta-tistically significant difference of the ARB and in ACEI,but ARB excels in ACEI discontinuation due to adverse reactions.Conclusion:the current evidence suggests that ARB is as effective as ACEI in reducing the risk of patients with all-cause mortalily,cardiovascular mortality, myocardial infarction and heart failure and better tolerated.